Patient Assessment, Drugs, Herbal and Cannabinoids
Mark Donaldson, BSP, RPH, PHARMD, FASHP, FACHELecture
Did you know that more than 20% of hospital admissions are due to adverse drug reactions? Just because dentists prescribe less than 10% of all available drugs, your patients may be taking others from the 90% with which you are not familiar. Since polypharmacy is the norm, especially in the over 65 year old population, this course should be considered essential to every practice setting today.
Do you have patients who are already on one prescription medication before they come to your office? How about four prescription medications? Did you know that the likelihood of a drug interaction in a patient on five medications is greater than 50%? What if you are the prescriber who writes that fifth prescription? With so many new medications, herbal products, over-the-counter drugs, and supplements available on the market, how can you be confident that the prescription you write is compatible with what your patient is currently taking?
Now what if these same patients are also experimenting with illicit drugs? How does the use of marijuana, cocaine, methamphetamine, crack, Salvia divinorum, khat bush, or designer drugs such as MDPV change your treatment plan? If substance abuse and dependence affects one in ten North Americans, this means one in ten of your patients. With the approval of both medical and recreational marijuana in the Evergreen state, the number of users who now present to the dental office is rapidly escalating.
This interactive program looks at some of the more common dental-specific drug and herbal interactions and their management with a particular focus on the dental realm. Further, the most common negative oral health sequelae due to cannabinoid use and the management of these patients will also be discussed. Case studies will augment the delivery of key points and a problem-based learning approach is encouraged so that each participant’s questions are addressed. After all, when an adverse drug reaction occurs due to a drug interaction, who is more at risk – you or your patient?
As a result of attending this program you will be able to:
- Describe the potential for drug-drug interactions and articulate strategies to avoid or manage them.
- Understand the principles of drug metabolism including liver enzyme induction and inhibition.
- Recognize reputable databases and references and how to utilize these tools to evaluate drug therapies and herbal interactions.
- Discuss the four main challenges of medically complex dental patients, the concept of risk and how to select and de-select appropriate patients.
- Describe the risk factors to consider when treating patients who use cannabinoids.
- Understand the medical evidence behind the safety and efficacy of cannabinoids.
Mark Donaldson received his baccalaureate degree from the University of British Columbia, and his Doctorate in Clinical Pharmacy from the University of Washington. He completed a residency at Vancouver General Hospital, and has practiced as a clinical pharmacy specialist, clinical coordinator and director of pharmacy services at many healthcare organizations in both Canada and the United States. He is currently the Associate Principal of Clinical Pharmacy for Vizient’s Advisory Solutions, and lives in Whitefish, Montana.
Dr. Donaldson is a Clinical Professor in the Department of Pharmacy at the University of Montana in Missoula, and Clinical Associate Professor in the School of Dentistry at the Oregon Health & Sciences University in Portland, Oregon. He has a special interest in dental pharmacology and has lectured internationally to both dental and medical practitioners. He has spent the last 20 years focusing on dental pharmacology and dental therapeutics, and is a leader in the field.
Dr. Donaldson has published numerous peer-reviewed works and textbook chapters. He currently serves on the Editorial Board for the Journal Healthcare Executive and the Journal of the American Dental Association and is a reviewer for over ten other different journals. He is board certified in healthcare management and is the Past-President and current Regent of the American College of Healthcare Executives’ Montana Chapter. Dr. Donaldson was named as the 2014 recipient of the Bowl of Hygeia for the state of Montana and is the 2016 recipient of the Dr. Thaddeus V. Weclew Award. This award is conferred upon an individual who has made outstanding contributions to the medical, dental and pharmacy literature.
- Dr. Donaldson has no relevant financial relationships to disclose.
- The staff of the University of Washington Office of Continuing Dental Education have no relevant financial relationships to disclose.
Saturday, September 21, 2019
University of Washington
Health Sciences Center – Room D209
Seattle, WA 98195
This course is designed for dentists, hygienists, dental assistants and office staff.
Registration and Continental Breakfast: 8:00am – 8:30am
Course: 8:30am – 4:30pm
TUITION – price includes lunch:
Until September 18, 2019 (after, $25 more)
$189/Hygienist, Dental Assistant, Office Staff
$260/Current Dental Alumni Member
* This course is eligible for a 10% tuition discount if you are a current member of the UW Dental Alumni Association.
The University of Washington is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
The University of Washington is a member of the Association for Continuing Dental Education.
University of Washington designates this activity for 7 continuing education credits.